retatrutide ly3437943 triple agonist glp-1 gip glucagon just posted the biggest weight-loss numbers ever recorded for a drug — 28.3% (≈70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric What Is Retatrutide? The Triple
Description
Ozempic, known generically as semaglutide, is a prescription medication belonging to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists
Physiol Rep 6(17):e13852
Very great product
Cost isn't just a number on a checkout page
Glucagon Receptor: The Third Arm Retatrutide takes this concept further by adding a third receptor target: glucagon
